The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

Correction for Gatza and Okada, J Immunol 169 (9) 5227-5235.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
The Journal of Immunology, 2003, 170: 5333.
Copyright © 2003 by The American Association of Immunologists

CORRECTION

CORRECTION

Erin Gatza and Craig Y. Okada. Tumor Cell Lysate-Pulsed Dendritic Cells Are More Effective Than TCR Id Protein Vaccines for Active Immunotherapy of T Cell Lymphoma. The Journal of Immunology 2002;169:5227–5235 .

The authors of this paper neglected to identify the source of a reagent used in the study. The source of the reagent is stated below.

"The C6VL TCR Id vaccine used in this study was prepared by conjugating recombinant TCR Id protein to KLH and mixing the conjugate with QS-21. QS-21 was provided by Antigenics, Inc. (Framingham, MA) under a material transfer agreement."





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS